Akamai Technologies vs Cloudflare
AKAM and NET side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AKAM and NET compare
Cloudflare is the larger company, worth 7.5 times as much as Akamai Technologies ($100.0B against $13.3B).
Cloudflare grew revenue faster over the last twelve months (33.5% versus 5.9% for Akamai Technologies).
Akamai Technologies keeps more of each dollar of sales as profit, with a net margin of 9.5% compared with −8.2% at Cloudflare.
Akamai Technologies scores higher on the StockData Score (10 against 9 for Cloudflare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AKAM | NET |
|---|---|---|
| Size and price | ||
| Market cap | $13.3B | $100.0B |
| Share price | $92.72 | $280.70 |
| Change, 1 year | 27.0% | 23.4% |
| Change, 5 years | −13.6% | 42.3% |
| Beta (5Y) | 0.83 | 2.27 |
| Employees | 11K | 5,156 |
| StockData Score | ||
| Total score | 10 (better) | 9 |
| Valuation score | 2 (better) | 0 |
| Growth score | 0 | 3 (better) |
| Performance score | 3 (better) | 1 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 33.4× | – |
| P/S | 3.1× (better) | 39.8× |
| P/B | 2.8× (better) | 61.7× |
| EV/EBITDA | 8.4× | – |
| P/FCF | 13.9× (better) | 287× |
| FCF yield | 7.2% (better) | 0.35% |
| Fair value | $96.48 | $76.27 |
| Margin of safety | 3.9% (better) | −268% |
| Growth | ||
| Revenue growth (TTM) | 5.9% | 33.5% (better) |
| Revenue growth, 5Y average | 5.6% | 38.1% (better) |
| Net income growth (TTM) | −3.2% | – |
| EPS growth (TTM) | −1.4% | – |
| EPS growth, 5Y average | −1.8% | – |
| Profitability | ||
| Gross margin | 57.5% | 72.6% (better) |
| Operating margin | 10.5% (better) | −14.1% |
| Net margin | 9.5% (better) | −8.2% |
| FCF margin | 22.1% (better) | 13.9% |
| Return on equity | 8.9% (better) | −14.4% |
| Return on invested capital | 15.3% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | 13.7× (better) | −30.9× |
| Current ratio | 1.64 | 1.82 (better) |
| Altman Z-score | 1.64 | 12.66 (better) |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | 4.6% | – |
| Shareholder yield | 4.6% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 111% | 79.9% |
| Held by insiders | 2.2% | 8.2% |
| Insider net buying, 12 months | −$17.1M (better) | −$660M |
| Short interest, % of float | 13.7% | 2.3% |
Go deeper
- AKAM stock overview
- AKAM income statement
- AKAM valuation and score
- NET stock overview
- NET income statement
- NET valuation and score
Other comparisons
- AKAM vs ALLE
- CRWD vs NET
- DBX vs NET
- DDOG vs NET
- DT vs NET
- GEN vs NET
- MDB vs NET
- NET vs OKTA
- NET vs RBLX
- NET vs TWLO
- NET vs YOU
- NET vs ZS
For information only, not investment advice. Check the source filings before relying on any figure.